PCSK9 Inhibitors: The New Frontier in Cholesterol Management
How PCSK9 inhibitors such as evolocumab lower LDL cholesterol, the outcome trial evidence, safety, who may benefit and access in Australia.
Articles on heart disease, prevention, and cardiac imaging by Dr Reza Moazzeni, MD FRACP, cardiologist in Sydney.
How PCSK9 inhibitors such as evolocumab lower LDL cholesterol, the outcome trial evidence, safety, who may benefit and access in Australia.
How bempedoic acid lowers LDL cholesterol by a different pathway from statins, the trial evidence, and where it may fit for people who cannot take statins.
A case report of probable amiodarone-induced leukocytoclastic vasculitis presenting as a purpuric leg rash, with diagnosis and management.

Familial hypercholesterolaemia (FH) is an inherited cause of high LDL cholesterol. How FH is diagnosed, when genetic testing helps and why family testing matters.

Two cases, post-thrombotic syndrome and traumatic lymphoedema, illustrating a systematic approach to acute and chronic swelling of one leg.
A case of secondary mitral regurgitation in heart failure showing why heart failure medicines and, in selected patients, CRT are usually the first step.
Cardiac asthma (cardiac cough) is cough and wheeze caused by heart failure. A short history of the term and a case with echocardiogram findings.

Two cases of marked sinus bradycardia and of low blood pressure with fainting after bariatric surgery, with a discussion of possible mechanisms.

Leg swelling is usually venous, cardiac, medicine-related or lymphatic. Learn why one leg versus both matters, the warning signs and when to see a doctor.

Five steps that lower heart attack risk: know your risk, treat blood pressure and cholesterol, stop smoking, move more and eat well, plus key numbers to know.
How the nocebo effect can contribute to symptoms blamed on statins, what trials such as SAMSON found, and why this matters for people stopping statins.

What a coronary calcium score measures, what results such as 0, 100 or 400 mean, who may benefit from the test, its cost in Australia and its limitations.